Editor's note - Page 9 of 19 - Express Pharma

USTR review could mean tough times ahead

Beyond the budget

Will a toothless drug price watchdog be good or bad for business?

Out with the old, on with the new

Where is the patient in the e-pharmacy debate?

Will quality trip or lift us up in 2019?

Achieving UNAIDS’ 90-90-90: A tall task

Dipping rupee to boost FY19 pharma revenues but …

Competition watch dog raps pharma sector for non-competitive market moves

The pharma play in Ayushman Bharat